Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant988 active trials8 approved drugs63 evidence items
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01509911 | A Clinical Trial of Anti-Angiogenic Drug Combination Tl-118 for Pancreatic Cancer Patients Who Are Starting Gemcitabine Treatment | unknown | Phase 2 | 99 | Tiltan Pharma Ltd.INDUSTRY | 2 | Feb 5, 2016 | clinicaltrials |
| NCT02634502 | Radiofrequency Ablation Combined With S-1 for Pancreatic Cancer With Liver Metastasis | unknown | Phase 2 | 30 | Fudan UniversityOTHER | 1 | Dec 18, 2015 | clinicaltrials |
| NCT02133079 |
| Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96 |
| unknown |
| Phase 1 / Phase 2 |
| 20 |
| Cure&Sure Biotech Co., LTDINDUSTRY |
| 1 |
| Dec 11, 2015 |
| clinicaltrials |
| NCT01882946 | Safety and Efficacy Study of DCVax-Direct in Solid Tumors | unknown | Phase 1 / Phase 2 | 60 | Northwest BiotherapeuticsINDUSTRY | 1 | Oct 7, 2015 | clinicaltrials |
| NCT02528526 | Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm(OXY1A) | unknown | Phase 1 / Phase 2 | 69 | University of ZurichOTHER | 1 | Aug 19, 2015 | clinicaltrials |
| NCT01608841 | The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib | unknown | Phase 2 | 88 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Feb 18, 2015 | clinicaltrials |
| NCT01898741 | Cone-beam CT Guided Stereotactic Radiation Therapy for Locally Advanced Pancreatic Cancer | unknown | Phase 2 | 30 | UMC UtrechtOTHER | 1 | Feb 3, 2015 | clinicaltrials |
| NCT02311439 | Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas | unknown | Phase 2 / Phase 3 | 1 | Assiut UniversityOTHER | 1 | Dec 8, 2014 | clinicaltrials |
| NCT02135822 | Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Advanced Pancreatic Cancer(NAPGAP) | unknown | Phase 2 | 30 | Chinese PLA General HospitalOTHER | 1 | May 16, 2014 | clinicaltrials |
| NCT01065870 | Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III) | unknown | Phase 2 / Phase 3 | 64 | Columbia UniversityOTHER | 1 | Jan 29, 2014 | clinicaltrials |
| NCT02038738 | 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors | unknown | Phase 1 / Phase 2 | 250 | Ochsner Health SystemOTHER | 1 | Jan 17, 2014 | clinicaltrials |
| NCT01074996 | Study of S-1 as Second Line Treatment on Advanced Pancreatic Cancers(APC-S1) | unknown | Phase 2 | 92 | The Affiliated Hospital of the Chinese Academy of Military Medical SciencesOTHER | 1 | Jan 16, 2014 | clinicaltrials |
| NCT00553683 | Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer | unknown | Phase 1 / Phase 2 | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT01941342 | Evaluation of Preoperative Biliary Drainage Before Pancreatoduodenectomy | unknown | Phase 2 | 274 | Southwest Hospital, ChinaOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00003780 | Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas | unknown | Phase 2 | 150 | Meyer PharmaceuticalsINDUSTRY | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00003797 | Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas | unknown | Phase 2 | 41 | Brown UniversityOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT01659502 | Investigator's Initiated Phase II Study for Pancreatic Cancer Patients | unknown | Phase 2 | 10 | Tiltan Pharma Ltd.INDUSTRY | 1 | Dec 5, 2013 | clinicaltrials |
| NCT01867892 | A Phase II Study of Locally Advanced Pancreatic Cancer | unknown | Phase 2 | 86 | National Health Research Institutes, TaiwanOTHER | 0 | Jun 4, 2013 | clinicaltrials |
| NCT01811277 | SOX Sequential S-1 in Advanced Biliary Tract Carcinoma(BTC)and Pancreatic Cancer | unknown | Phase 2 | 40 | Peking UniversityOTHER | 1 | Mar 15, 2013 | clinicaltrials |
| NCT01796782 | QYHJ Granules Versus Xeloda in Metastatic Pancreatic Cancer | unknown | Phase 2 | 60 | Fudan UniversityOTHER | 0 | Feb 22, 2013 | clinicaltrials |
| NCT01655641 | Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery(TMGS) | unknown | Phase 2 / Phase 3 | 118 | Tribhuvan University Teaching Hospital, Institute Of Medicine.OTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT00658840 | Concurrent Chemo-radiotherapy With Capecitabine for Unresectable Locally Advanced Pancreatic Carcinoma | unknown | Phase 2 | 55 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 3, 2012 | clinicaltrials |
| NCT00082862 | Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer | unknown | Phase 2 | 48 | The University of Texas Health Science Center, HoustonOTHER | 1 | Feb 13, 2012 | clinicaltrials |
| NCT00795977 | Preoperative Intratumor Dendritic Cells Injection Immunotherapy for Patients With Pancreatic Cancer | unknown | Phase 1 / Phase 2 | 20 | Fukushima Medical UniversityOTHER | 1 | Sep 8, 2011 | clinicaltrials |
| NCT01372735 | Trial of Neoadjuvant Short Course IMRT Followed by Surgery and IORT for Resectable Pancreatic Cancer(NEOPANC) | unknown | Phase 1 / Phase 2 | 46 | University Hospital HeidelbergOTHER | 1 | Jun 14, 2011 | clinicaltrials |
| NCT01333631 | Valproic Acid With Chemoradiotherapy for Pancreatic Cancer | unknown | Phase 2 | 20 | Soroka University Medical CenterOTHER | 0 | Apr 12, 2011 | clinicaltrials |
| NCT01333332 | Radiotherapy With Chemotherapy as Neoadjuvant Therapy of Resectable and Borderline Resectable Pancreas Cancer | unknown | Phase 2 | 35 | University of VirginiaOTHER | 1 | Apr 11, 2011 | clinicaltrials |
| NCT00178763 | Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer(FR-WB-TT) | unknown | Phase 2 | 36 | The University of Texas Health Science Center, HoustonOTHER | 1 | Mar 3, 2011 | clinicaltrials |
| NCT00690300 | Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic Cancer | unknown | Phase 2 | 44 | University of UlmOTHER | 1 | Mar 3, 2010 | clinicaltrials |
| NCT01063192 | A Study of Locally Advanced Pancreatic Cancer | unknown | Phase 2 | 73 | National Health Research Institutes, TaiwanOTHER | 0 | Feb 5, 2010 | clinicaltrials |
| NCT00006117 | Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 2 | Oct 30, 2009 | clinicaltrials |
| NCT00683358 | Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer | unknown | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | May 7, 2009 | clinicaltrials |
| NCT00024375 | DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer | unknown | Phase 2 | — | TheradexINDUSTRY | 4 | Feb 18, 2009 | clinicaltrials |
| NCT00010062 | Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 2 | Feb 9, 2009 | clinicaltrials |
| NCT00010088 | Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 2 | Feb 9, 2009 | clinicaltrials |
| NCT00275119 | Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00758381 | Metastatic Advanced Pancreas Sorafenib(MAPS) | unknown | Phase 2 | 114 | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato DigerenteOTHER | 1 | Oct 10, 2008 | clinicaltrials |
| NCT00024362 | BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery | unknown | Phase 2 | — | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00149578 | A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic Cancer | unknown | Phase 2 | 45 | National Health Research Institutes, TaiwanOTHER | 1 | May 17, 2007 | clinicaltrials |
| NCT00323583 | Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer | unknown | Phase 2 | 80 | Seattle Cancer Treatment and Wellness CenterOTHER | 1 | May 8, 2007 | clinicaltrials |
| NCT00108875 | Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer | unknown | Phase 1 / Phase 2 | 70 | Julius-Maximilians UniversityOTHER | 1 | Jul 28, 2006 | clinicaltrials |
| NCT00346281 | 32P BioSiliconTM in Addition to Gemcitabine in Pancreatic Cancer | unknown | Phase 2 | 15 | pSiMedica LimitedINDUSTRY | 2 | Jun 29, 2006 | clinicaltrials |
| NCT00197431 | Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer | unknown | Phase 2 | — | Hamamatsu UniversityOTHER | 1 | Mar 22, 2006 | clinicaltrials |
| NCT00057395 | A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies | unknown | Phase 1 / Phase 2 | 40 | Aronex PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00081549 | Aroplatin and Gemcitabine in Patients With Advanced Pancreatic Cancer Resistant to Standard Therapies | unknown | Phase 1 / Phase 2 | 111 | Aronex PharmaceuticalsINDUSTRY | 0 | Jun 24, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Feb 5, 2016source: clinicaltrials